vs

Side-by-side financial comparison of Lulu's Fashion Lounge Holdings, Inc. (LVLU) and RECURSION PHARMACEUTICALS, INC. (RXRX). Click either name above to swap in a different company.

Lulu's Fashion Lounge Holdings, Inc. is the larger business by last-quarter revenue ($66.1M vs $35.5M, roughly 1.9× RECURSION PHARMACEUTICALS, INC.). Lulu's Fashion Lounge Holdings, Inc. runs the higher net margin — -48.2% vs -304.2%, a 256.1% gap on every dollar of revenue. On growth, RECURSION PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (681.7% vs -11.8%). Lulu's Fashion Lounge Holdings, Inc. produced more free cash flow last quarter ($-2.6M vs $-47.3M). Over the past eight quarters, RECURSION PHARMACEUTICALS, INC.'s revenue compounded faster (60.5% CAGR vs -14.7%).

Lulu's Fashion Lounge Holdings, Inc. is a direct-to-consumer women's fashion retailer offering affordable, trendy apparel, footwear, and accessories. It primarily serves Gen Z and millennial consumers across North America, operating mainly via its e-commerce platform, with limited pop-up physical locations to boost customer engagement.

Recursion Pharmaceuticals is a clinical-stage biotechnology company that combines artificial intelligence and large-scale high-throughput biological experimentation to discover and develop innovative therapies for rare diseases, oncology, inflammatory disorders, and other areas of unmet medical need. It primarily operates in North America and partners with global biopharmaceutical firms to advance its robust therapeutic pipeline.

LVLU vs RXRX — Head-to-Head

Bigger by revenue
LVLU
LVLU
1.9× larger
LVLU
$66.1M
$35.5M
RXRX
Growing faster (revenue YoY)
RXRX
RXRX
+693.5% gap
RXRX
681.7%
-11.8%
LVLU
Higher net margin
LVLU
LVLU
256.1% more per $
LVLU
-48.2%
-304.2%
RXRX
More free cash flow
LVLU
LVLU
$44.8M more FCF
LVLU
$-2.6M
$-47.3M
RXRX
Faster 2-yr revenue CAGR
RXRX
RXRX
Annualised
RXRX
60.5%
-14.7%
LVLU

Income Statement — Q4 FY2024 vs Q4 FY2025

Metric
LVLU
LVLU
RXRX
RXRX
Revenue
$66.1M
$35.5M
Net Profit
$-31.9M
$-108.1M
Gross Margin
37.9%
59.8%
Operating Margin
-52.8%
-304.8%
Net Margin
-48.2%
-304.2%
Revenue YoY
-11.8%
681.7%
Net Profit YoY
-340.9%
39.6%
EPS (diluted)
$-13.46
$-0.17

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
LVLU
LVLU
RXRX
RXRX
Q4 25
$35.5M
Q3 25
$5.2M
Q2 25
$19.2M
Q1 25
$14.7M
Q4 24
$66.1M
$4.5M
Q3 24
$80.5M
$26.1M
Q2 24
$92.0M
$14.4M
Q1 24
$77.3M
$13.8M
Net Profit
LVLU
LVLU
RXRX
RXRX
Q4 25
$-108.1M
Q3 25
$-162.3M
Q2 25
$-171.9M
Q1 25
$-202.5M
Q4 24
$-31.9M
$-178.9M
Q3 24
$-6.9M
$-95.8M
Q2 24
$-10.8M
$-97.5M
Q1 24
$-5.7M
$-91.4M
Gross Margin
LVLU
LVLU
RXRX
RXRX
Q4 25
59.8%
Q3 25
-183.8%
Q2 25
-4.9%
Q1 25
-48.0%
Q4 24
37.9%
-181.4%
Q3 24
38.1%
53.7%
Q2 24
45.5%
36.2%
Q1 24
42.3%
19.1%
Operating Margin
LVLU
LVLU
RXRX
RXRX
Q4 25
-304.8%
Q3 25
-3327.6%
Q2 25
-916.8%
Q1 25
-1297.9%
Q4 24
-52.8%
-4042.4%
Q3 24
-8.5%
-377.1%
Q2 24
-4.9%
-697.4%
Q1 24
-8.0%
-698.4%
Net Margin
LVLU
LVLU
RXRX
RXRX
Q4 25
-304.2%
Q3 25
-3135.3%
Q2 25
-894.2%
Q1 25
-1373.3%
Q4 24
-48.2%
-3935.5%
Q3 24
-8.5%
-367.5%
Q2 24
-11.7%
-676.6%
Q1 24
-7.4%
-662.4%
EPS (diluted)
LVLU
LVLU
RXRX
RXRX
Q4 25
$-0.17
Q3 25
$-0.36
Q2 25
$-0.41
Q1 25
$-0.50
Q4 24
$-13.46
$-0.56
Q3 24
$-2.47
$-0.34
Q2 24
$-3.92
$-0.40
Q1 24
$-0.15
$-0.39

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
LVLU
LVLU
RXRX
RXRX
Cash + ST InvestmentsLiquidity on hand
$4.5M
$743.3M
Total DebtLower is stronger
$9.6M
Stockholders' EquityBook value
$13.4M
$1.1B
Total Assets
$108.2M
$1.5B
Debt / EquityLower = less leverage
0.01×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
LVLU
LVLU
RXRX
RXRX
Q4 25
$743.3M
Q3 25
$659.8M
Q2 25
$525.1M
Q1 25
$500.5M
Q4 24
$4.5M
$594.4M
Q3 24
$6.3M
$427.6M
Q2 24
$1.8M
$474.3M
Q1 24
$5.5M
$296.3M
Total Debt
LVLU
LVLU
RXRX
RXRX
Q4 25
$9.6M
Q3 25
$11.9M
Q2 25
$14.2M
Q1 25
$16.4M
Q4 24
$19.0M
Q3 24
$20.5M
Q2 24
$22.9M
Q1 24
Stockholders' Equity
LVLU
LVLU
RXRX
RXRX
Q4 25
$1.1B
Q3 25
$1.0B
Q2 25
$919.1M
Q1 25
$933.9M
Q4 24
$13.4M
$1.0B
Q3 24
$43.8M
$524.6M
Q2 24
$48.7M
$584.4M
Q1 24
$57.7M
$401.2M
Total Assets
LVLU
LVLU
RXRX
RXRX
Q4 25
$1.5B
Q3 25
$1.4B
Q2 25
$1.3B
Q1 25
$1.3B
Q4 24
$108.2M
$1.4B
Q3 24
$153.5M
$726.5M
Q2 24
$145.3M
$775.9M
Q1 24
$160.6M
$557.8M
Debt / Equity
LVLU
LVLU
RXRX
RXRX
Q4 25
0.01×
Q3 25
0.01×
Q2 25
0.02×
Q1 25
0.02×
Q4 24
0.02×
Q3 24
0.04×
Q2 24
0.04×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
LVLU
LVLU
RXRX
RXRX
Operating Cash FlowLast quarter
$-2.5M
$-46.1M
Free Cash FlowOCF − Capex
$-2.6M
$-47.3M
FCF MarginFCF / Revenue
-3.9%
-133.1%
Capex IntensityCapex / Revenue
0.0%
3.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$1.3M
$-378.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
LVLU
LVLU
RXRX
RXRX
Q4 25
$-46.1M
Q3 25
$-117.4M
Q2 25
$-76.4M
Q1 25
$-132.0M
Q4 24
$-2.5M
$-115.4M
Q3 24
$-5.5M
$-59.2M
Q2 24
$3.7M
$-82.2M
Q1 24
$6.9M
$-102.3M
Free Cash Flow
LVLU
LVLU
RXRX
RXRX
Q4 25
$-47.3M
Q3 25
$-117.6M
Q2 25
$-79.6M
Q1 25
$-133.8M
Q4 24
$-2.6M
$-116.7M
Q3 24
$-5.9M
$-63.8M
Q2 24
$3.4M
$-83.4M
Q1 24
$6.4M
$-109.0M
FCF Margin
LVLU
LVLU
RXRX
RXRX
Q4 25
-133.1%
Q3 25
-2272.5%
Q2 25
-413.9%
Q1 25
-907.4%
Q4 24
-3.9%
-2567.7%
Q3 24
-7.3%
-244.6%
Q2 24
3.7%
-578.5%
Q1 24
8.3%
-789.9%
Capex Intensity
LVLU
LVLU
RXRX
RXRX
Q4 25
3.5%
Q3 25
4.7%
Q2 25
16.4%
Q1 25
12.4%
Q4 24
0.0%
28.6%
Q3 24
0.5%
17.5%
Q2 24
0.4%
8.2%
Q1 24
0.7%
48.2%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

LVLU
LVLU

Single Reportable Segment$63.0M95%
Other$2.4M4%
Stored Value Cards$750.0K1%

RXRX
RXRX

Segment breakdown not available.

Related Comparisons